Unaudited quarterly results for quarter ended 31.12.2025

Going ConcernPat NegativeDebt Equity ThresholdResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹14.01

prior close

₹13.54

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+0.9% vs market

Commodity Chemicals peers, median of 53sector+0.0%+1.9% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9+1.0+0.9+0.0+1.9

Next day

-1.5+0.5-2.0-0.3-1.2

+0.1-0.0+0.2-0.4+0.5

-2.4-1.5-0.9-1.6-0.8

+2.4-2.2+4.6-3.1+5.5

+5.8-1.2+7.0-3.2+9.0

-0.1-2.4+2.3-3.6+3.5

15d

-13.2-8.8-4.4-7.6-5.6

-5.2-8.3+3.1-9.7+4.5

+20.6-3.5+24.1-5.9+26.4

+22.8+6.4+16.4+1.6+21.2

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gayatri BioOrganics reported zero revenue from operations and zero total income for the third quarter as well as for the nine months ended December 31, 2025 — no business activity across periods. The company posted a net loss of ₹21.71 lakhs in Q3 FY26 versus a loss of ₹16.06 lakhs in Q3 FY25, with the nine-month loss widening to ₹69.13 lakhs from ₹55.19 lakhs a year ago. The company has negative net worth of ₹(3,589.31) lakhs against a paid-up equity capital of ₹7,878.81 lakhs, indicating accumulated losses have wiped out shareholder equity. Note 4 explicitly states the results are prepared on a going concern basis relying on a comfort letter from the promoters, signalling the company cannot sustain itself on its own operations.

Likely market impact

This is a deeply negative filing for shareholders — the company has no revenue, recurring losses, fully eroded net worth, and its survival depends on promoter support. Expect continued pressure on the stock and heightened risk of trading suspension or deeper solvency concerns if no business restart or capital infusion is announced.